<p>Cary Street Partners Financial LLC 在最近提交給證券交易委員會的 13F 表格中表示，在第二季度將其在貝克頓、迪金森公司（NYSE:BDX - 免費報告）的股份減少了 58.6%。該公司在此期間出售了 5,556 股後，持有 3,930 股該醫療儀器供應商的股票。Cary Street Partners Financial LLC 在貝克頓、迪金森公司的持股在最近一個季度末價值 677,000 美元。</p>
<ul>
<li>直覺外科公司提供從其 52 周高點的買入機會</li>
</ul>
<p>其他機構投資者和對沖基金最近也買賣了該公司的股票。先鋒集團在第二季度將其在貝克頓、迪金森公司的股份增加了 15.4%。先鋒集團現在擁有 32,308,749 股該醫療儀器供應商的股票，價值 5,565,182,000 美元，此前在上個季度購買了額外的 4,305,947 股。挪威銀行在第二季度獲得了貝克頓、迪金森公司的新頭寸，價值約 653,377,000 美元。第一鷹投資管理公司在第二季度將其在貝克頓、迪金森公司的股份增加了 59.2%。第一鷹投資管理公司現在擁有 8,786,190 股該醫療儀器供應商的股票，價值 1,513,421,000 美元，此前在上個季度購買了額外的 3,268,478 股。GQG Partners LLC 在第一季度獲得了貝克頓、迪金森公司的新股份，價值 689,833,000 美元。最後，馬薩諸塞金融服務公司在第二季度將其在貝克頓、迪金森公司的股份增加了 24.4%。馬薩諸塞金融服務公司現在擁有 8,514,446 股該醫療儀器供應商的股票，價值 1,466,613,000 美元，此前在上個季度獲得了額外的 1,670,590 股。86.97% 的股票由機構投資者和對沖基金持有。</p>
<h2>內部人士下注</h2>
<p>在貝克頓、迪金森公司的其他消息中，董事貝特拉姆·L·斯科特於 11 月 7 日星期五出售了 217 股公司的股票。該股票以平均價格 176.58 美元出售，總價值為 38,317.86 美元。交易後，該董事直接持有 35,816 股公司的股票，價值 6,324,389.28 美元。這代表其持股減少了 0.60%。該出售在向 SEC 提交的文件中披露，文件可通過此超鏈接獲取。在上個季度，內部人士出售了價值 73,922 美元的 407 股公司股票。公司內部人士持有 0.36% 的公司股票。</p>
<h2>分析師升級和降級</h2>
<ul>
<li>至少有 30 年分紅增長的醫療保健股票</li>
</ul>
<p>一些股票研究分析師最近對該公司發佈了報告。阿古斯在 9 月 15 日的研究報告中將貝克頓、迪金森公司的目標價格從 220.00 美元上調至 230.00 美元。派珀·桑德勒在 11 月 7 日的研究報告中將貝克頓、迪金森公司的目標價格從 200.00 美元下調至 190.00 美元，並對該股票給予 “中性” 評級。摩根士丹利在 12 月 2 日的研究報告中將貝克頓、迪金森公司的目標價格從 197.00 美元上調至 210.00 美元，並給予該公司 “增持” 評級。加拿大皇家銀行在 11 月 7 日的研究報告中將貝克頓、迪金森公司的目標價格從 211.00 美元下調至 202.00 美元，並對該股票給予 “行業表現” 評級。最後，韋斯評級在 10 月 8 日的研究報告中重申了對貝克頓、迪金森公司的 “持有（c-）” 評級。四位分析師對該股票給予買入評級，九位分析師對該公司的股票給予持有評級。根據 MarketBeat 的數據，貝克頓、迪金森公司的平均評級為 “持有”，平均目標價格為 204.91 美元。</p>
<p><strong>閲讀我們最新的 BDX 股票分析</strong></p>
<h2>貝克頓、迪金森公司的價格表現</h2>
<p>NYSE BDX 週四開盤價為 198.44 美元。該公司的債務與股本比率為 0.69，流動比率為 1.11，速動比率為 0.64。該公司的市值為 566.4 億美元，市盈率為 34.04，市盈率增長比率為 1.74，貝塔值為 0.25。該公司的 50 日簡單移動平均線為 188.58 美元，200 日簡單移動平均線為 184.19 美元。貝克頓、迪金森公司的 52 周低點為 162.29 美元，52 周高點為 251.99 美元。</p>
<p>貝克頓、迪金森公司（NYSE:BDX - 獲取免費報告）最後一次發佈季度收益數據是在 4 月 14 日星期四。該醫療儀器供應商報告該季度每股收益為 4.10 美元。該公司該季度的收入為 53.2 億美元。貝克頓、迪金森公司的淨利潤率為 7.68%，股本回報率為 16.42%。股票研究分析師預測，貝克頓、迪金森公司將在當前財政年度發佈每股收益 14.43 美元。</p>
<h2>貝克頓、迪金森公司增加分紅</h2>
<p>該公司最近還披露了一項季度分紅，將於 12 月 31 日星期三支付。12 月 8 日星期一的登記投資者將獲得每股 1.05 美元的分紅。該分紅的除息日為 12 月 8 日星期一。這是貝克頓、迪金森公司之前每季度 1.04 美元分紅的積極變化。這代表年化分紅為 4.20 美元，收益率為 2.1%。貝克頓、迪金森公司的派息比率為 72.04%。</p>
<h2>貝克頓、迪金森公司公司簡介</h2>
<p>（免費報告）</p>
<p>貝克頓、迪金森公司開發、製造和銷售醫療用品、設備、實驗室設備和診斷產品，服務於全球的醫療機構、醫生、生命科學研究人員、臨牀實驗室、製藥行業和公眾。該公司分為三個部門：BD 醫療、BD 生命科學和 BD 介入。</p>
<h2>進一步閲讀</h2>
<ul>
<li>我們更看好的五隻股票：Becton, Dickinson and Company</li>
<li>使用 MarketBeat 股息税計算器</li>
<li>市場動量：3 只有望大幅突破的股票</li>
<li>便士股票適合你的投資組合嗎？</li>
<li>Casey’s General Stores 將繼續上漲的 3 個理由</li>
<li>支撐與阻力的基礎知識</li>
<li>黃金交叉警報：3 只具有重大上漲潛力的股票</li>
</ul>
<p><strong>想知道其他對 BDX 持有的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com 獲取 Becton, Dickinson and Company (NYSE:BDX - 免費報告) 的最新 13F 文件和內部交易信息。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUJEWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUJEWA"/></p>
<p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
<h2>你現在應該投資 1,000 美元於 Becton, Dickinson and Company 嗎？</h2>
<p>在考慮 Becton, Dickinson and Company 之前，你需要聽聽這個。</p>
<p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前... 而 Becton, Dickinson and Company 並不在名單上。</p>
<p>雖然 Becton, Dickinson and Company 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
<p>在這裏查看這五隻股票</p>

碧迪醫療

<p>Cary Street Partners Financial LLC 在第二季度根據最新的 SEC 文件減少了對碧迪醫療（NYSE:BDX）58.6% 的持倉。該公司出售了 5,556 股，保留了價值 67.7 萬美元的 3,930 股。其他機構投資者也調整了他們的持倉。分析師對 BDX 的評級不一，平均目標價為 204.91 美元。該股票週四以 198.44 美元開盤，市值為 566.4 億美元</p>

<p>Cary Street Partners Financial LLC reduced its position in shares of Becton, Dickinson and Company (NYSE:BDX - Free Report) by 58.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities &amp; Exchange Commission. The firm owned 3,930 shares of the medical instruments supplier's stock after selling 5,556 shares during the period. Cary Street Partners Financial LLC's holdings in Becton, Dickinson and Company were worth $677,000 at the end of the most recent quarter.</p>
<div class="lb-trans"><p>Cary Street Partners Financial LLC 在最近提交給證券交易委員會的 13F 表格中表示，在第二季度將其在貝克頓、迪金森公司（NYSE:BDX - 免費報告）的股份減少了 58.6%。該公司在此期間出售了 5,556 股後，持有 3,930 股該醫療儀器供應商的股票。Cary Street Partners Financial LLC 在貝克頓、迪金森公司的持股在最近一個季度末價值 677,000 美元。</p>
</div><ul>
<li>Intuitive Surgical Gives Buying Opportunity Off Its 52 Week Highs</li>
</ul>
<div class="lb-trans"><ul>
<li>直覺外科公司提供從其 52 周高點的買入機會</li>
</ul>
</div><p>Other institutional investors and hedge funds also recently bought and sold shares of the company. Vanguard Group Inc. raised its holdings in shares of Becton, Dickinson and Company by 15.4% in the 2nd quarter. Vanguard Group Inc. now owns 32,308,749 shares of the medical instruments supplier's stock worth $5,565,182,000 after purchasing an additional 4,305,947 shares in the last quarter. Norges Bank acquired a new position in Becton, Dickinson and Company in the second quarter worth approximately $653,377,000. First Eagle Investment Management LLC increased its holdings in shares of Becton, Dickinson and Company by 59.2% in the second quarter. First Eagle Investment Management LLC now owns 8,786,190 shares of the medical instruments supplier's stock valued at $1,513,421,000 after buying an additional 3,268,478 shares in the last quarter. GQG Partners LLC acquired a new stake in shares of Becton, Dickinson and Company during the 1st quarter valued at $689,833,000. Finally, Massachusetts Financial Services Co. MA boosted its stake in shares of Becton, Dickinson and Company by 24.4% during the 2nd quarter. Massachusetts Financial Services Co. MA now owns 8,514,446 shares of the medical instruments supplier's stock worth $1,466,613,000 after acquiring an additional 1,670,590 shares in the last quarter. 86.97% of the stock is owned by institutional investors and hedge funds.</p>
<div class="lb-trans"><p>其他機構投資者和對沖基金最近也買賣了該公司的股票。先鋒集團在第二季度將其在貝克頓、迪金森公司的股份增加了 15.4%。先鋒集團現在擁有 32,308,749 股該醫療儀器供應商的股票，價值 5,565,182,000 美元，此前在上個季度購買了額外的 4,305,947 股。挪威銀行在第二季度獲得了貝克頓、迪金森公司的新頭寸，價值約 653,377,000 美元。第一鷹投資管理公司在第二季度將其在貝克頓、迪金森公司的股份增加了 59.2%。第一鷹投資管理公司現在擁有 8,786,190 股該醫療儀器供應商的股票，價值 1,513,421,000 美元，此前在上個季度購買了額外的 3,268,478 股。GQG Partners LLC 在第一季度獲得了貝克頓、迪金森公司的新股份，價值 689,833,000 美元。最後，馬薩諸塞金融服務公司在第二季度將其在貝克頓、迪金森公司的股份增加了 24.4%。馬薩諸塞金融服務公司現在擁有 8,514,446 股該醫療儀器供應商的股票，價值 1,466,613,000 美元，此前在上個季度獲得了額外的 1,670,590 股。86.97% 的股票由機構投資者和對沖基金持有。</p>
</div><h2>Insiders Place Their Bets</h2>
<div class="lb-trans"><h2>內部人士下注</h2>
</div><p>In other Becton, Dickinson and Company news, Director Bertram L. Scott sold 217 shares of the company's stock in a transaction dated Friday, November 7th. The stock was sold at an average price of $176.58, for a total value of $38,317.86. Following the transaction, the director directly owned 35,816 shares of the company's stock, valued at $6,324,389.28. This represents a 0.60% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Over the last quarter, insiders sold 407 shares of company stock valued at $73,922. Corporate insiders own 0.36% of the company's stock.</p>
<div class="lb-trans"><p>在貝克頓、迪金森公司的其他消息中，董事貝特拉姆·L·斯科特於 11 月 7 日星期五出售了 217 股公司的股票。該股票以平均價格 176.58 美元出售，總價值為 38,317.86 美元。交易後，該董事直接持有 35,816 股公司的股票，價值 6,324,389.28 美元。這代表其持股減少了 0.60%。該出售在向 SEC 提交的文件中披露，文件可通過此超鏈接獲取。在上個季度，內部人士出售了價值 73,922 美元的 407 股公司股票。公司內部人士持有 0.36% 的公司股票。</p>
</div><h2>Analyst Upgrades and Downgrades</h2>
<div class="lb-trans"><h2>分析師升級和降級</h2>
</div><ul>
<li>Healthcare Stocks With at Least 30 Years of Dividend Increases</li>
</ul>
<div class="lb-trans"><ul>
<li>至少有 30 年分紅增長的醫療保健股票</li>
</ul>
</div><p>A number of equities research analysts have recently issued reports on the company. Argus boosted their target price on Becton, Dickinson and Company from $220.00 to $230.00 in a research report on Monday, September 15th. Piper Sandler dropped their price target on Becton, Dickinson and Company from $200.00 to $190.00 and set a &#34;neutral&#34; rating on the stock in a research note on Friday, November 7th. Morgan Stanley upped their price objective on shares of Becton, Dickinson and Company from $197.00 to $210.00 and gave the company an &#34;overweight&#34; rating in a research note on Tuesday, December 2nd. Royal Bank Of Canada dropped their target price on shares of Becton, Dickinson and Company from $211.00 to $202.00 and set a &#34;sector perform&#34; rating on the stock in a research report on Friday, November 7th. Finally, Weiss Ratings restated a &#34;hold (c-)&#34; rating on shares of Becton, Dickinson and Company in a research report on Wednesday, October 8th. Four analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company's stock. Based on data from MarketBeat, Becton, Dickinson and Company has an average rating of &#34;Hold&#34; and an average price target of $204.91.</p>
<div class="lb-trans"><p>一些股票研究分析師最近對該公司發佈了報告。阿古斯在 9 月 15 日的研究報告中將貝克頓、迪金森公司的目標價格從 220.00 美元上調至 230.00 美元。派珀·桑德勒在 11 月 7 日的研究報告中將貝克頓、迪金森公司的目標價格從 200.00 美元下調至 190.00 美元，並對該股票給予 “中性” 評級。摩根士丹利在 12 月 2 日的研究報告中將貝克頓、迪金森公司的目標價格從 197.00 美元上調至 210.00 美元，並給予該公司 “增持” 評級。加拿大皇家銀行在 11 月 7 日的研究報告中將貝克頓、迪金森公司的目標價格從 211.00 美元下調至 202.00 美元，並對該股票給予 “行業表現” 評級。最後，韋斯評級在 10 月 8 日的研究報告中重申了對貝克頓、迪金森公司的 “持有（c-）” 評級。四位分析師對該股票給予買入評級，九位分析師對該公司的股票給予持有評級。根據 MarketBeat 的數據，貝克頓、迪金森公司的平均評級為 “持有”，平均目標價格為 204.91 美元。</p>
</div><p><strong>Read Our Latest Stock Analysis on BDX</strong></p>
<div class="lb-trans"><p><strong>閲讀我們最新的 BDX 股票分析</strong></p>
</div><h2>Becton, Dickinson and Company Price Performance</h2>
<div class="lb-trans"><h2>貝克頓、迪金森公司的價格表現</h2>
</div><p>NYSE BDX opened at $198.44 on Thursday. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.11 and a quick ratio of 0.64. The firm has a market capitalization of $56.64 billion, a price-to-earnings ratio of 34.04, a price-to-earnings-growth ratio of 1.74 and a beta of 0.25. The company has a 50 day simple moving average of $188.58 and a 200-day simple moving average of $184.19. Becton, Dickinson and Company has a 52-week low of $162.29 and a 52-week high of $251.99.</p>
<div class="lb-trans"><p>NYSE BDX 週四開盤價為 198.44 美元。該公司的債務與股本比率為 0.69，流動比率為 1.11，速動比率為 0.64。該公司的市值為 566.4 億美元，市盈率為 34.04，市盈率增長比率為 1.74，貝塔值為 0.25。該公司的 50 日簡單移動平均線為 188.58 美元，200 日簡單移動平均線為 184.19 美元。貝克頓、迪金森公司的 52 周低點為 162.29 美元，52 周高點為 251.99 美元。</p>
</div><p>Becton, Dickinson and Company (NYSE:BDX - Get Free Report) last released its quarterly earnings data on Thursday, April 14th. The medical instruments supplier reported $4.10 earnings per share for the quarter. The firm had revenue of $5.32 billion for the quarter. Becton, Dickinson and Company had a net margin of 7.68% and a return on equity of 16.42%. Equities research analysts predict that Becton, Dickinson and Company will post 14.43 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>貝克頓、迪金森公司（NYSE:BDX - 獲取免費報告）最後一次發佈季度收益數據是在 4 月 14 日星期四。該醫療儀器供應商報告該季度每股收益為 4.10 美元。該公司該季度的收入為 53.2 億美元。貝克頓、迪金森公司的淨利潤率為 7.68%，股本回報率為 16.42%。股票研究分析師預測，貝克頓、迪金森公司將在當前財政年度發佈每股收益 14.43 美元。</p>
</div><h2>Becton, Dickinson and Company Increases Dividend</h2>
<div class="lb-trans"><h2>貝克頓、迪金森公司增加分紅</h2>
</div><p>The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 31st. Investors of record on Monday, December 8th will be given a dividend of $1.05 per share. The ex-dividend date of this dividend is Monday, December 8th. This is a positive change from Becton, Dickinson and Company's previous quarterly dividend of $1.04. This represents a $4.20 dividend on an annualized basis and a yield of 2.1%. Becton, Dickinson and Company's payout ratio is 72.04%.</p>
<div class="lb-trans"><p>該公司最近還披露了一項季度分紅，將於 12 月 31 日星期三支付。12 月 8 日星期一的登記投資者將獲得每股 1.05 美元的分紅。該分紅的除息日為 12 月 8 日星期一。這是貝克頓、迪金森公司之前每季度 1.04 美元分紅的積極變化。這代表年化分紅為 4.20 美元，收益率為 2.1%。貝克頓、迪金森公司的派息比率為 72.04%。</p>
</div><h2>Becton, Dickinson and Company Company Profile</h2>
<div class="lb-trans"><h2>貝克頓、迪金森公司公司簡介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免費報告）</p>
</div><p>Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company operates in three segments: BD Medical, BD Life Sciences, and BD Interventional.</p>
<div class="lb-trans"><p>貝克頓、迪金森公司開發、製造和銷售醫療用品、設備、實驗室設備和診斷產品，服務於全球的醫療機構、醫生、生命科學研究人員、臨牀實驗室、製藥行業和公眾。該公司分為三個部門：BD 醫療、BD 生命科學和 BD 介入。</p>
</div><h2>Further Reading</h2>
<div class="lb-trans"><h2>進一步閲讀</h2>
</div><ul>
<li>Five stocks we like better than Becton, Dickinson and Company</li>
<li>Using the MarketBeat Dividend Tax Calculator</li>
<li>Market Momentum: 3 Stocks Poised for Major Breakouts</li>
<li>Are Penny Stocks a Good Fit for Your Portfolio?</li>
<li>3 Reasons Casey’s General Stores Will Continue Trending Higher</li>
<li>The Basics of Support and Resistance</li>
<li>Golden Cross Alert: 3 Stocks With Major Upside Potential</li>
</ul>
<div class="lb-trans"><ul>
<li>我們更看好的五隻股票：Becton, Dickinson and Company</li>
<li>使用 MarketBeat 股息税計算器</li>
<li>市場動量：3 只有望大幅突破的股票</li>
<li>便士股票適合你的投資組合嗎？</li>
<li>Casey’s General Stores 將繼續上漲的 3 個理由</li>
<li>支撐與阻力的基礎知識</li>
<li>黃金交叉警報：3 只具有重大上漲潛力的股票</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding BDX?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他對 BDX 持有的對沖基金嗎？</strong> 請訪問 HoldingsChannel.com 獲取 Becton, Dickinson and Company (NYSE:BDX - 免費報告) 的最新 13F 文件和內部交易信息。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUJEWA" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=BDX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即時新聞提醒由敍事科學技術和 MarketBeat 的金融數據生成，旨在為讀者提供最快的報道和公正的覆蓋。如對本故事有任何問題或意見，請發送郵件至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Becton, Dickinson and Company Right Now?</h2>
<div class="lb-trans"><h2>你現在應該投資 1,000 美元於 Becton, Dickinson and Company 嗎？</h2>
</div><p>Before you consider Becton, Dickinson and Company, you'll want to hear this.</p>
<div class="lb-trans"><p>在考慮 Becton, Dickinson and Company 之前，你需要聽聽這個。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Becton, Dickinson and Company wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟蹤華爾街頂級評級和表現最佳的研究分析師及其推薦給客户的股票。MarketBeat 已識別出五隻頂級分析師悄悄建議客户現在購買的股票，以便在更廣泛的市場注意到之前... 而 Becton, Dickinson and Company 並不在名單上。</p>
</div><p>While Becton, Dickinson and Company currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>雖然 Becton, Dickinson and Company 目前在分析師中被評為持有評級，但頂級分析師認為這五隻股票更值得購買。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在這裏查看這五隻股票</p>
</div>

Cary Street Partners Financial LLC 出售了碧迪醫療公司 $BDX 的股份